| COVID-19 |
1 |
1 |
| Child |
0 |
0.99 |
| Cancer |
0 |
0.98 |
| COVID-19 Vaccination in Pediatrics |
0 |
0.95 |
| Covid-19 and Cancer |
0 |
0.96 |
| Cancer in Childhood |
0 |
0.97 |
| Revenue and Practice Management |
0 |
0.33 |
| Salary and Compensation |
0 |
0.3 |
| Social Determinants of Health |
0 |
0.21 |
| Adolescent Medicine |
0 |
0.94 |
| Pediatric Oncology |
0 |
0.13 |
| Hospital |
0 |
0.1 |
| Non-Hodgkin Lymphoma (NHL) |
0 |
0.09 |
| Acute Lymphoblastic Leukemia |
0 |
0.07 |
| Lymphoblastic Lymphoma |
0 |
0.07 |
| Acute Leukemia |
0 |
0.06 |
| Stem Cell Research and Therapy |
0 |
0.06 |
| Antiviral Agents |
0 |
0.05 |
| Critical Illness |
0 |
0.93 |
| Immunization |
0 |
0.92 |
| Leukemia |
0 |
0.05 |
| Lymphocytes |
0 |
0.05 |
| Lymphoma |
0 |
0.05 |
| Neutrophils |
0 |
0.05 |
| Tumor |
0 |
0.05 |
| Cell Transplantation |
0 |
0.04 |
| Central Nervous System |
0 |
0.03 |
| Chemotherapy |
0 |
0.03 |
| Clinical Research |
0 |
0.03 |
| Echocardiography |
0 |
0.03 |
| Fellowship |
0 |
0.03 |
| Geriatrics |
0 |
0.03 |
| Health Care Quality, Access, and Evaluation |
0 |
0.9 |
| Refractory |
0 |
0.03 |
| Transplantation |
0 |
0.03 |
| UK Site Content |
0 |
0.03 |
| Cardiovascular Imaging |
0 |
0.02 |
| Neutropenia |
0 |
0.02 |